Updates on the Development of a Highly Selective Inhibitor for HFpEF Treatment
Time: 11:00 am
day: Day Two
Details:
- Deep dive into novel target for heart failure through a high content screening approach in iPS-derived cardiomyocytes
- Working through multiple mechanisms of action including blocking fibrosis, inflammation and modulating metabolic pathways
